Monroe Capital [MRCC] vs Ellington Financial [EARN] Detailed Stock Comparison
Monroe Capital
NASDAQ
Loading...
Ellington Financial
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Monroe Capital wins in 13 metrics, Ellington Financial wins in 5 metrics, with 0 ties. Monroe Capital appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Monroe Capital | Ellington Financial | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 83.00 | 20.39 | Ellington Financial |
| Price-to-Book Ratio | 0.90 | 0.94 | Monroe Capital |
| Debt-to-Equity Ratio | 116.14 | 226.91 | Monroe Capital |
| PEG Ratio | -0.52 | -0.09 | Monroe Capital |
| Profit Margin (TTM) | 3.74% | -14.61% | Monroe Capital |
| Operating Margin (TTM) | 72.81% | 75.59% | Ellington Financial |
| EBITDA Margin (TTM) | 72.81% | 75.59% | Ellington Financial |
| Return on Equity | 1.01% | -2.82% | Monroe Capital |
| Return on Assets (TTM) | 5.45% | -0.60% | Monroe Capital |
| Free Cash Flow (TTM) | $35.96M | $9.11M | Monroe Capital |
| Dividend Yield | 15.72% | 14.04% | Monroe Capital |
| 1-Year Return | -4.42% | -16.59% | Monroe Capital |
| Price-to-Sales Ratio (TTM) | 3.16 | 5.98 | Monroe Capital |
| Enterprise Value | $368.00M | $715.11M | Ellington Financial |
| EV/Revenue Ratio | 7.18 | 19.92 | Monroe Capital |
| Revenue per Share (TTM) | $2 | $1 | Monroe Capital |
| Earnings per Share (Diluted) | $0.09 | $0.28 | Ellington Financial |
| Beta (Stock Volatility) | 0.97 | 1.30 | Monroe Capital |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Monroe Capital vs Ellington Financial Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Monroe Capital | -0.26% | 1.75% | 21.94% | 19.62% | -7.13% | -12.40% |
| Ellington Financial | -0.35% | -3.40% | -0.87% | 1.25% | -10.83% | -14.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Monroe Capital | -4.42% | -11.27% | 0.00% | -48.75% | -50.07% | -50.07% |
| Ellington Financial | -16.59% | -27.46% | -49.38% | -56.77% | -70.99% | -70.99% |
Performance & Financial Health Analysis: Monroe Capital vs Ellington Financial
| Metric | MRCC | EARN |
|---|---|---|
| Market Information | ||
| Market Cap | $184.60M | $214.46M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 73,270 | 347,110 |
| 90 Day Avg. Volume | 119,557 | 390,077 |
| Last Close | $7.56 | $5.68 |
| 52 Week Range | $5.96 - $8.85 | $4.33 - $7.11 |
| % from 52W High | -14.58% | -20.11% |
| All-Time High | $16.37 (Sep 05, 2016) | $19.85 (May 20, 2013) |
| % from All-Time High | -53.82% | -71.39% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.37% | -0.34% |
| Quarterly Earnings Growth | -1.13% | -1.90% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | -0.15% |
| Operating Margin (TTM) | 0.73% | 0.76% |
| Return on Equity (TTM) | 0.01% | -0.03% |
| Debt to Equity (MRQ) | 116.14 | 226.91 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.29 | $6.08 |
| Cash per Share (MRQ) | $0.11 | $0.48 |
| Operating Cash Flow (TTM) | $118.27M | $19.53M |
| Levered Free Cash Flow (TTM) | $11.17M | $6.59M |
| Dividends | ||
| Last 12-Month Dividend Yield | 15.72% | 14.04% |
| Last 12-Month Dividend | $1.00 | $0.80 |
Valuation & Enterprise Metrics Analysis: Monroe Capital vs Ellington Financial
| Metric | MRCC | EARN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 83.00 | 20.39 |
| Forward P/E | 7.40 | 4.84 |
| PEG Ratio | -0.52 | -0.09 |
| Price to Sales (TTM) | 3.16 | 5.98 |
| Price to Book (MRQ) | 0.90 | 0.94 |
| Market Capitalization | ||
| Market Capitalization | $184.60M | $214.46M |
| Enterprise Value | $368.00M | $715.11M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.18 | 19.92 |
| Enterprise to EBITDA | N/A | N/A |
| Risk & Other Metrics | ||
| Beta | 0.97 | 1.30 |
| Book Value per Share (MRQ) | $8.29 | $6.08 |
Financial Statements Comparison: Monroe Capital vs Ellington Financial
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MRCC | EARN |
|---|---|---|
| Revenue/Sales | $-568,000 | $-5.29M |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $-1.91M | $-7.88M |
| Income Tax | $-43,000 | $-6,000 |
| Net Income (Profit) | $-1.87M | $-7.87M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MRCC | EARN |
|---|---|---|
| Cash & Equivalents | $6.46M | $17.38M |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $269.09M | N/A |
| Total Shareholders Equity | $186.88M | $228.50M |
| Retained Earnings | $-110.86M | $-171.74M |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MRCC | EARN |
|---|---|---|
| Operating Cash Flow | $-1.67M | $-7.20M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $26.07M | $9.21M |
| Debt Repayment | $-49.10M | N/A |
| Common Stock Repurchase | N/A | $-979,000 |
Short Interest & Institutional Ownership Analysis
| Metric | MRCC | EARN |
|---|---|---|
| Shares Short | 98,698 | 238,322 |
| Short Ratio | 0.75 | 0.61 |
| Short % of Float | 0.00% | 0.01% |
| Average Daily Volume (10 Day) | 73,270 | 347,110 |
| Average Daily Volume (90 Day) | 119,557 | 390,077 |
| Shares Outstanding | 21.67M | 29.65M |
| Float Shares | N/A | 37.05M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 0.17% | 0.13% |
Dividend Analysis & Yield Comparison: Monroe Capital vs Ellington Financial
| Metric | MRCC | EARN |
|---|---|---|
| Last 12-Month Dividend | $1.00 | $0.80 |
| Last 12-Month Dividend Yield | 15.72% | 14.04% |
| 3-Year Avg Annual Dividend | $1.00 | $0.85 |
| 3-Year Avg Dividend Yield | 3.30% | 1.18% |
| 3-Year Total Dividends | $3.00 | $2.56 |
| Ex-Dividend Date | Jun 16, 2025 | Mar 31, 2025 |